We leverage commercial investment through co-funding of research projects to provide value for money, to benefit from mutual and equitable collaborations, and to accelerate translation of scientific discoveries into patient benefit, at pace and scale. Additionally, this provides our researchers with an opportunity to develop business skills and facilitate further interactions in the future.
We work closely with Imperial College London’s Industry Partnerships – a team of specialised professionals dedicated to supporting academic-industry interactions. Together we identify and nurture industry collaborations with BRC researchers in areas of mutual interest, where novel ideas are co-developed and risks are shared. These range from individual projects and fellowships, to multi-year partnership programmes that align with our strategic research interests.
The infrastructure for supporting implementation of our industrial partnership strategy is well-established at Imperial. We work with Industry Partnerships and Commercialisation Team and the Joint Research Office to ensure efficient contract and cost negotiations, and to facilitate support, delivery and growth of industry-collaborative research projects through BRC-supported infrastructure and ‘bridging’ funding.
Between 2017-2022, we leveraged >£68M of collaborative industrial investment from the life sciences industry, supporting our early stage clinical and biomedical research. Some of our major strategic industry partnerships are listed below, and you can find out more about them on our IPC website.
Want to work with us?
We are always eager to hear about your projects and ideas for any industrial collaborations. Please do not hesitate to get in touch with us at enterprise@imperial.ac.uk.
NIHR Imperial BRC is an active partner in MedCity, promoting and growing innovation in South-East England. We also work closely with NIHR Office for Clinical Research Infrastructure, to facilitate national NOCRI Industry Signposting service.
